JG
AMRI

Joel Greenblatt’s Albany Molecular Research Inc AMRI Stock Holding History

Joel Greenblatt’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-102,934
Closed -$2.07M – 1114
2014
Q2 		$2.07M Sell
102,934
-94,837
-48% -$1.61M 0.03% 524
2014
Q1 		$3.68M Sell
197,771
-31,666
-14% -$436K 0.06% 422
2013
Q4 		$2.31M Buy
229,437
+1,221
+0.5% +$14.8K 0.06% 452
2013
Q3 		$2.94M Buy
+228,216
New +$2.81M 0.1% 316

Other funds holding AMRI

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
PIP
Permian Investment Partners Dallas, Texas $911M AUM 0.66% 1-Year Est. Return
EWM
Evercore Wealth Management New York $7.07B AUM 24.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Joel Greenblatt's AMRI Position: Q3 2014 in Review

Joel Greenblatt sold out of Albany Molecular Research Inc (AMRI) in Q3 2014, closing a stake of 102,934 shares — an estimated $2.07M sold.

Joel Greenblatt first reported a position in AMRI in Q3 2013 and held it in 4 quarters. The position peaked at $3.68M in Q1 2014. 143 funds tracked by Wall St. Rank hold AMRI as of Q3 2014.

  • Joel Greenblatt reported no remaining Albany Molecular Research Inc position as of Q3 2014 after selling out during the quarter.
  • Joel Greenblatt sold 102,934 Albany Molecular Research Inc shares in Q3 2014, an estimated $2.07M.
  • Joel Greenblatt first reported a position in Albany Molecular Research Inc in Q3 2013 and held it in 4 quarters.
  • Joel Greenblatt's Albany Molecular Research Inc position peaked at $3.68M in Q1 2014.
  • 143 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2014.

Based on Gotham Asset Management's 13F filing for Q3 2014, filed 14 Nov 2014.